EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
21 hedge funds and large institutions have $41.8M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+16
Holders Change %
+320%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$9.23M |
2 |
6CM
683 Capital Management
New York
|
+$5.99M |
3 |
SC
Shay Capital
New York
|
+$4.5M |
4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$3.51M |
5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.01M |
Top Sellers
1 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.82M |
2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$34.8K |